Clinical Trial: Biomarker for GM1/GM2 - Gangliosidoses

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Biomarker for GM1/GM2-Gangliosidoses - AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL

Brief Summary: Development of a new MS-based biomarker for the early and sensitive diagnosis of metachromatic leukodystrophy disease from plasma and saliva. Testing for clinical robustness, specificity and long-term stability of the biomarker.